Disease | demyelinating disease |
Phenotype | C0035435|rheumatic diseases |
Sentences | 2 |
PubMedID- 22152489 | Conclusions: it is not clear whether tnf antagonists increase the incidence of demyelinating diseases in patients with rheumatic diseases. |
PubMedID- 20864146 | Objectives: to estimate the rate of demyelinating diseases in patients with rheumatic diseases treated with tumor necrosis factor (tnf) antagonists and to describe the cases reported to 3 different pharmacovigilance sources. |
Page: 1